Select a Region
North America

Browsing Archive: Scientific InsightsScientific Insights | EVERSANA - Part 5

EVERSANA
Posted on 2월 1, 20232/1/23

Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis

EVERSANA
Posted on 2월 1, 20232/1/23

Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer

EVERSANA
Posted on 2월 1, 20232/1/23

Meta-Analysis of Proptosis Response in Thyroid Eye Disease: Efficacy of EUGOGO Recommended Treatment Regimen With IV Methylprednisolone

EVERSANA
Posted on 2월 1, 20232/1/23

Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain

EVERSANA
Posted on 2월 1, 20232/1/23

Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies

EVERSANA
Posted on 2월 1, 20232/1/23

Annual Cardiovascular-related Hospitalization Days Avoided With Tafamidis Treatment in Patients With Transthyretin Amyloid Cardiomyopathy

EVERSANA
Posted on 2월 1, 20232/1/23

Modelling Lifetime Survival Gain in Patients With Transthyretin Amyloid Cardiomyopathy and Baseline NYHA Class III: An Analysis of ATTR-ACT and Long-Term Extension Study

EVERSANA
Posted on 2월 1, 20232/1/23

Efficacy classification of modern therapies in multiple sclerosis

EVERSANA
Posted on 2월 1, 20232/1/23

Network Meta-analysis of Disease-modifying Therapies for Relapsing Multiple Sclerosis Based on Confirmed Disability Progression: Investigating the Influence of Cross-trial Differences in Endpoint Definition

EVERSANA
Posted on 2월 1, 20232/1/23

Relapse Reduction by Disease-modifying Therapies for Relapsing Multiple Sclerosis: A Network Meta-analysis

Scientific Insights